Management Strategies for Microalbuminuria in Diabetes Mellitus – an Overview

Authors

  • K Kishore Nepalgunj Medical College, Nepalgunj
  • A Sharma Nepalgunj Medical College, Nepalgunj

DOI:

https://doi.org/10.31729/jnma.642

Abstract

Microalbuminuria (MA) in individuals with diabetes mellitus (DM) is associated with markedly reduced
survival, increased risk of cardiovascular disease and is predictive of later development of an overt Diabetic
Kidney Disease (DKD) and progressive renal failure. Patients with type 1 DM from 5 years after diagnosis
and type 2 DM from the time of diagnosis should be screened annually for MA by sensitive stick test in spot
collection or Albumin Excretion Rate (AER) in the timed collection of urine. AER. of 20-200µg/min (30-
300mg/24hr) or Albumin : Creatinine ratio (ACR) >2.5 is labelled as MA. ACE Inhibitor / Angiotensin II
Receptor Blocker (ARB) therapy along with improved glycaemic control is the key to prevent or slow the
progression of DKD.

Key Words: Microalbuminuria, Diabetes Mellitus, Diabetic Kidney Disease.

Downloads

Published

2003-07-01

How to Cite

Kishore, K., & Sharma, A. (2003). Management Strategies for Microalbuminuria in Diabetes Mellitus – an Overview. Journal of Nepal Medical Association, 42(148). https://doi.org/10.31729/jnma.642

Issue

Vol. 42 No. 148 (2003)

Section

Review Article

License

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.